Rupert Haynes, CEO of FSD Pharma speaks about pivoting from medical marijuana to a pharmaceutical company.

“I was really intrigued by the whole cannabinoid therapy areas of innovation that was coming forward and most recently have joined FSD Pharma. They wanted someone to help them transform from a medical marijuana company which it is today and pivot into a pharmaceutical company and that’s what they’ve brought me in to do. What you see is the medical marijuana business complementing the pharmaceutical endeavours but the pharmaceutical part of the business will go its own way. The types of disorders we’re looking at is really around CNS in particular. If we want a solid dose formulation, we’re not going to build that in-house, we’re going to partner with people that already have that capability. SciCann are looking at at IBS, Ulcerative Colitis is looking at the gut application with cannabinoids. I think we have to really make sure that the choices we make will bring new medicines to the market as quick as we possibly can.” – Rupert Haynes, CEO of FSD Pharma

“Our vision when we bought the Kraft plant was to become innovative and the largest grower in the world. We have 620,000 square feet of grow space. We have another 40 acres in the back which we can grow. We have the infrastructure, we have the financing, we have the management team and we look forward to a great future for FSD Pharma and our investors.” – Michael Ash, CCO of FSD Pharma

FSD Pharma is a publicly traded company on the Canadian Securities Exchange under the symbol HUGE. The Company, through its wholly-owned subsidiary FV Pharma Inc., holds an ACMPR license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). HUGE, made history on its first day of trading on the Canadian Securities Exchange (“CSE”), broke the all-time record for volume traded, making the company the largest volume traded in a single first day of trading in the history of the CSE. HUGE then went on to break the all-time record for weekly volume traded, monthly volume traded and yearly volume traded in the history of the CSE. HUGE broke the yearly volume traded record in just less than 2 months and traded over a Billion shares in less than 2 months.

For more information on FSD Pharma (HUGE:CSE) please fill out the form below.